Novoheart Holdings

Novoheart Holdings is committed to revolutionizing drug development and cardiac therapy development by utilizing their various proprietary bioengineered human heart constructs, further developing them into transplantable grafts to provide cell-based regenerative cardiac therapies with superior safety and efficacy.